Skip to main content

Table 2 Urinary OspA results compared to serology, clinical diagnosis and treatment status of N = 168 patients suspected of having early stage LB, and healthy controls

From: Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis

Categories

Details

Total

OspA Pos

OspA Neg

Non Lyme

Asymptomatic (EM Neg, serology ND)

117

0

117

Symptomatic, joint pain (EM Neg, serology Neg)

3

0

3

Untreated, clinical diagnosis of LB

EM Pos (serology: 12 Pos, 5 Neg, 3 Eq, 4 ND)

24

24

0

Antibiotic treatment for a clinical diagnosis of LB

EM rash present at the time of urine collection during the treatment course (Serology: 4 Pos, 6 Neg)

10

10

0

Arthritis Pos, EM Neg (serology: 6 Pos)

6

6

0

Converted to EM Neg (Serology: 4 Pos, 4 Neg, 8/8 urinary OspA Pos prior to therapy)

8

0

8

  1. OspA pos urinary OspA test positive, OspA neg urinary OspA test negative, EM Erythema Migrans, ND serology not done